Hepatitis B and C
Authors:
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 64 (3) , 641-658
Abstract
No abstract availableKeywords
Funding Information
- Roche
- Gilead Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
- Bristol-Myers Squibb
This publication has 102 references indexed in Scilit:
- Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4European Journal of Clinical Microbiology & Infectious Diseases, 2013
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis CGastroenterology, 2011
- Influence of Body Mass Index on Outcome of Pediatric Chronic Hepatitis C Virus InfectionJournal of Pediatric Gastroenterology and Nutrition, 2010
- Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated InterferonJournal of Pediatric Gastroenterology and Nutrition, 2010
- A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis BCurrent Hepatitis Reports, 2010
- Contemporary Clinical Research of Traditional Chinese Medicines for Chronic Hepatitis B in China: An Analytical ReviewHepatology, 2010
- Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional OutcomesJournal of Pediatric Gastroenterology and Nutrition, 2009
- Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohortAmerican Journal of Obstetrics and Gynecology, 2008
- Host Genetic Factors and Vaccine-Induced Immunity to Hepatitis B Virus InfectionPLOS ONE, 2008